etodolac has been researched along with Carcinoma, Anaplastic in 4 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
| Excerpt | Relevance | Reference |
|---|---|---|
| "As part of our screening program for cancer inhibitory agents effective specifically in the promotion stage of cancer development, we have evaluated the possible inhibitory effects of 36 non-steroidal anti-inflammatory drugs (NSAIDs) on the Epstein-Barr virus early antigen (EBV-EA) activation which was induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells." | 1.31 | Inhibition of epstein-barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugs. ( Azuine, MA; Kapadia, GJ; Konoshima, T; Nishino, H; Takasaki, M; Takayasu, J; Tokuda, H, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, T | 1 |
| Murano, M | 1 |
| Yoda, Y | 1 |
| Kuramoto, T | 1 |
| Kakimoto, K | 1 |
| Ishida, K | 1 |
| Kawakami, K | 1 |
| Abe, Y | 1 |
| Morita, E | 1 |
| Murano, N | 1 |
| Tokioka, S | 1 |
| Maemura, K | 1 |
| Umegaki, E | 1 |
| Higuchi, K | 1 |
| Noda, M | 1 |
| Tatsumi, Y | 1 |
| Tomizawa, M | 1 |
| Takama, T | 1 |
| Mitsufuji, S | 1 |
| Sugihara, H | 1 |
| Kashima, K | 1 |
| Hattori, T | 1 |
| Tsuneoka, N | 1 |
| Tajima, Y | 1 |
| Kitazato, A | 1 |
| Fukuda, K | 1 |
| Kitajima, T | 1 |
| Kuroki, T | 1 |
| Onizuka, S | 1 |
| Kanematsu, T | 1 |
| Kapadia, GJ | 1 |
| Azuine, MA | 1 |
| Takayasu, J | 1 |
| Konoshima, T | 1 |
| Takasaki, M | 1 |
| Nishino, H | 1 |
| Tokuda, H | 1 |
4 other studies available for etodolac and Carcinoma, Anaplastic
| Article | Year |
|---|---|
R-etodolac induces E-cadherin and suppresses colitis-related mouse colon tumorigenesis.
Topics: Animals; Antineoplastic Agents; Cadherins; Carcinoma; Colitis; Colonic Neoplasms; Cyclooxygenase 2; | 2010 |
Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
Topics: alpha Catenin; Animals; beta Catenin; Caco-2 Cells; Cadherins; Carcinoma; Cyclooxygenase 2; Cyclooxy | 2002 |
Chemopreventative effect of a cyclooxygenase-2-specific inhibitor (etodolac) on chemically induced biliary carcinogenesis in hamsters.
Topics: Animals; Biliary Tract Neoplasms; Carcinoma; Choledochostomy; Cricetinae; Cyclooxygenase 2; Cyclooxy | 2005 |
Inhibition of epstein-barr virus early antigen activation promoted by 12-O-tetradecanoylphorbol-13-acetate by the non-steroidal anti-inflammatory drugs.
Topics: Acetates; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Viral; Benzene; Carcinogens; Carcinoma; | 2000 |